PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $358,874 | +398.4% | 96,993 | -0.0% | 0.01% | +600.0% |
Q3 2022 | $72,000 | -5.3% | 97,019 | -0.8% | 0.00% | 0.0% |
Q2 2022 | $76,000 | -14.6% | 97,827 | -0.0% | 0.00% | 0.0% |
Q1 2022 | $89,000 | -99.2% | 97,851 | -92.9% | 0.00% | -98.4% |
Q4 2021 | $11,047,000 | +14.5% | 1,379,123 | +19.6% | 0.06% | +26.0% |
Q3 2021 | $9,650,000 | +176.0% | 1,152,912 | +122.3% | 0.05% | +194.1% |
Q2 2021 | $3,496,000 | – | 518,733 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |